2023
DOI: 10.1016/j.biopha.2023.115558
|View full text |Cite
|
Sign up to set email alerts
|

Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?

Kiarash Saleki,
Parsa Alijanizadeh,
Abbas Azadmehr
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 177 publications
0
2
0
Order By: Relevance
“…For the future, we suggest design of therapeutics targeting infammatory pathways in COVID-19. Using in silico vaccinology to target key infammatory molecules may be a rapid and promising approach to achieve this goal [29,30].…”
Section: Discussionmentioning
confidence: 99%
“…For the future, we suggest design of therapeutics targeting infammatory pathways in COVID-19. Using in silico vaccinology to target key infammatory molecules may be a rapid and promising approach to achieve this goal [29,30].…”
Section: Discussionmentioning
confidence: 99%
“…4 Thus, hyperinflammation is a major problem in COVID-19 cases. 5 As the pathological damage caused by COVID-19 involves the immune system, any factor that regulates the immune response may likewise regulate the consequences of COVID-19. 6 The pathological features of human severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) remain to be completely discovered; however its immune pathogenesis is known to be related to the feedback imbalance of the immune system.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, NRPs play a major role in the hyperinflammatory injury of the lung, nervous system, kidneys, liver, pancreas, and heart in COVID-19 cases. These effects result from interaction with specific regions of the SARS-CoV2 spike protein, and vascular endothelial growth factor (VEGF) receptors (VEGFR1/2) ( 5 , 6 ), highlighting the role of multi-organ neuroimmunopathological injury in COVID-19.…”
mentioning
confidence: 99%